782016001: Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quaternary ammonium compound (product)\Glycopyrronium-containing product\...

\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Product manufactured as parenteral dose form (product)\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product manufactured as parenteral dose form (product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3752320013 Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3752321012 Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3752322017 Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has manufactured dose form	Solution for injection	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator value	500	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Is a	Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Glycopyrronium bromide	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator value	en	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Count of base of active ingredient	to	false	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the numerator unit for the concentration strength of a product.	mcg	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Glycopyrronium bromide	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator value	en	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator value	2.5	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the numerator unit for the concentration strength of a product.	mg	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the numerator unit for the concentration strength of a product.	mcg	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Glycopyrronium bromide	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Glycopyrronium bromide	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3752320013	Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752321012	Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752322017	Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core